1.02—Nanoparticle-based drug delivery to prevent heart failure

Nanoparticle-based solutions that target the molecular signatures of myocardial infarction and prevent progression to heart failure. These nanoparticles intravenously deliver inhibitors of fibroblast activation protein alpha (FAP) directly to affected heart tissue, minimizing off-target effects.